CV Sciences' GAAP loss for 3 months of 2022 was $2.217 million, down 29.1% from $3.127 million in the prior year. Revenue decreased 8.2% to $4.447 million from $4.844 million a year earlier.
CV Sciences' GAAP loss for 3 months of 2022 was $2.217 million, down 29.1% from $3.127 million in the prior year. Revenue decreased 8.2% to $4.447 million from $4.844 million a year earlier. 
ir.cvsciences.com
English (US) 